Entertainment Wire Massachusetts: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Entertainment Wire Massachusetts.

Press releases published on October 19, 2026

Oct. 19, 2026

Fall Family Reset with Microban 24, Wyndham Hotels & Resorts, and Planet Oat, in discussion with YourUpdateTV

Indeterminate GlobeNewswire

Oct. 19, 2026

The Hospitality Show Sets Visionary Stage Program for 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Forge’s Fierce Life Sciences Announces 2026 Fierce Innovation Awards Finalists and Unveils the Fierce Vanguard Gala

Indeterminate GlobeNewswire

Oct. 19, 2026

2026 “General Managers to Watch” Award Winners Announced by Forge’s Hotel Management

Indeterminate GlobeNewswire

Oct. 19, 2026

Cerence AI Named Growth and Innovation Index Leader in Frost Radar™ for AI-Powered In-Car Assistants

Indeterminate GlobeNewswire

Oct. 19, 2026

Beacon Biosignals Partners with Project Sleep to Shorten the Path to Diagnosis for People with Idiopathic Hypersomnia and Narcolepsy

Indeterminate GlobeNewswire

Oct. 19, 2026

Proof and Circle Show How AI Agents Can Prove Who They Act For and Pay in USDC

Indeterminate GlobeNewswire

Oct. 19, 2026

Daily AI Use Nearly Doubles Among Marketers as Measurement Lags

Indeterminate GlobeNewswire

Oct. 19, 2026

Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Stingray Unveils Ford Streaming Radio and Lincoln Streaming Radio Apps to Enhance the In-Vehicle Audio Experience

Indeterminate GlobeNewswire

Oct. 19, 2026

Stingray dévoile les applications Ford Radio Numérique et Lincoln Radio Numérique, conçues pour enrichir l'expérience audio à bord

Indeterminate GlobeNewswire

Oct. 19, 2026

Miracles Surpasses 100,000 Personalized Children's Books, Now Printed in the USA for American Families

Indeterminate GlobeNewswire

Oct. 19, 2026

Biogen to Present New Data Across Nephrology Portfolio, Including Long-term EMPAVELI® (pegcetacoplan) Phase 3 Results, at American Society of Nephrology (ASN) Kidney Week

Indeterminate GlobeNewswire

Oct. 19, 2026

Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at IDWeek 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Georgia Personal Injury Statute of Limitations Explained in HelloNation Featuring Personal Injury Attorney D. Seth Holliday

Indeterminate GlobeNewswire

Oct. 19, 2026

EyePoint Announces Strategic Prioritization

Indeterminate GlobeNewswire

Oct. 19, 2026

Parabilis Medicines to Present Updated Clinical Data for Zolucatetide in Patients with Desmoid Tumors at ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Ethyreal Bio Achieves Proof of Mechanism in First-in-Human Study of ETHY-001 and Initiates First Patient Cohorts to Advance Development in Thyroid Eye Disease (TED) and Graves’ Disease (GD)

Indeterminate GlobeNewswire

Oct. 19, 2026

EyePoint Announces Topline Results from LUCIA, the Second Pivotal Phase 3 Clinical Trial of DURAVYU™ in Wet AMD

Indeterminate GlobeNewswire

Oct. 19, 2026

Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP)

Indeterminate GlobeNewswire